Dornase Alfa and Hypertonic Saline: Pass the Salt?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Sala MA;Sala MA; Jain M; Jain M
  • Source:
    Chest [Chest] 2023 Oct; Vol. 164 (4), pp. 807-808.
  • Publication Type:
    Editorial; Comment
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE
    • Publication Information:
      Publication: 2016- : New York : Elsevier
      Original Publication: Chicago : American College of Chest Physicians
    • Subject Terms:
      Deoxyribonuclease I*/therapeutic use ; Expectorants* ; Recombinant Proteins*/therapeutic use ; Saline Solution, Hypertonic*/therapeutic use; Humans ; Sodium Chloride/therapeutic use
    • Abstract:
      Competing Interests: Financial/Nonfinancial Disclosures None declared.
    • Comments:
      Comment on: Chest. 2023 Oct;164(4):860-871. (PMID: 37244586)
    • Accession Number:
      EC 3.1.21.1 (Deoxyribonuclease I)
      EC 3.1.21.1 (dornase alfa)
      0 (Expectorants)
      0 (Recombinant Proteins)
      0 (Saline Solution, Hypertonic)
      451W47IQ8X (Sodium Chloride)
    • Publication Date:
      Date Created: 20231007 Date Completed: 20231016 Latest Revision: 20231016
    • Publication Date:
      20231215
    • Accession Number:
      10.1016/j.chest.2023.06.036
    • Accession Number:
      37805234